241 related articles for article (PubMed ID: 19203098)
1. Immune markers of disease and therapeutic intervention in type 1 diabetes.
Roep BO
Novartis Found Symp; 2008; 292():159-71; discussion 171-3, 202-3. PubMed ID: 19203098
[TBL] [Abstract][Full Text] [Related]
2. T-cell assays to determine disease activity and clinical efficacy of immune therapy in type 1 diabetes.
van de Linde P; Roep BO
Am J Ther; 2005; 12(6):573-9. PubMed ID: 16280651
[TBL] [Abstract][Full Text] [Related]
3. The role of T-cells in the pathogenesis of Type 1 diabetes: from cause to cure.
Roep BO
Diabetologia; 2003 Mar; 46(3):305-21. PubMed ID: 12687328
[TBL] [Abstract][Full Text] [Related]
4. Identification of Candidate Tolerogenic CD8(+) T Cell Epitopes for Therapy of Type 1 Diabetes in the NOD Mouse Model.
Yu C; Burns JC; Robinson WH; Utz PJ; Ho PP; Steinman L; Frey AB
J Diabetes Res; 2016; 2016():9083103. PubMed ID: 27069933
[TBL] [Abstract][Full Text] [Related]
5. Genetic and therapeutic control of diabetogenic CD8+ T cells.
Santamaria P
Novartis Found Symp; 2008; 292():130-6; discussion 136-45, 202-3. PubMed ID: 19209463
[TBL] [Abstract][Full Text] [Related]
6. Humoral and cellular immune responses to proinsulin in adults with newly diagnosed type 1 diabetes.
Narendran P; Williams AJ; Elsegood K; Leech NJ; Dayan CM
Diabetes Metab Res Rev; 2003; 19(1):52-9. PubMed ID: 12592644
[TBL] [Abstract][Full Text] [Related]
7. Immunotherapy of type 1 diabetes.
Li L; Yi Z; Tisch R; Wang B
Arch Immunol Ther Exp (Warsz); 2008; 56(4):227-36. PubMed ID: 18726144
[TBL] [Abstract][Full Text] [Related]
8. APC-targeted proinsulin expression inactivates insulin-specific memory CD8
Reeves PL; Rudraraju R; Liu X; Wong FS; Hamilton-Williams EE; Steptoe RJ
Immunol Cell Biol; 2017 Oct; 95(9):765-774. PubMed ID: 28611473
[TBL] [Abstract][Full Text] [Related]
9. Cellular and molecular pathogenic mechanisms of insulin-dependent diabetes mellitus.
Yoon JW; Jun HS
Ann N Y Acad Sci; 2001 Apr; 928():200-11. PubMed ID: 11795511
[TBL] [Abstract][Full Text] [Related]
10. Customized cell-based treatment options to combat autoimmunity and restore beta-cell function in type 1 diabetes mellitus: current protocols and future perspectives.
Fändrich F; Ungefroren H
Adv Exp Med Biol; 2010; 654():641-65. PubMed ID: 20217518
[TBL] [Abstract][Full Text] [Related]
11. Autoreactive T cell responses in insulin-dependent (Type 1) diabetes mellitus. Report of the first international workshop for standardization of T cell assays.
Roep BO; Atkinson MA; van Endert PM; Gottlieb PA; Wilson SB; Sachs JA
J Autoimmun; 1999 Sep; 13(2):267-82. PubMed ID: 10479395
[TBL] [Abstract][Full Text] [Related]
12. Perinatal autoimmunity in offspring of diabetic parents. The German Multicenter BABY-DIAB study: detection of humoral immune responses to islet antigens in early childhood.
Roll U; Christie MR; Füchtenbusch M; Payton MA; Hawkes CJ; Ziegler AG
Diabetes; 1996 Jul; 45(7):967-73. PubMed ID: 8666150
[TBL] [Abstract][Full Text] [Related]
13. On the pathogenicity of autoantigen-specific T-cell receptors.
Burton AR; Vincent E; Arnold PY; Lennon GP; Smeltzer M; Li CS; Haskins K; Hutton J; Tisch RM; Sercarz EE; Santamaria P; Workman CJ; Vignali DA
Diabetes; 2008 May; 57(5):1321-30. PubMed ID: 18299317
[TBL] [Abstract][Full Text] [Related]
14. Autoimmune diabetes: the role of T cells, MHC molecules and autoantigens.
Durinovic-Belló I
Autoimmunity; 1998; 27(3):159-77. PubMed ID: 9609134
[TBL] [Abstract][Full Text] [Related]
15. Different diabetogenic potential of autoaggressive CD8+ clones associated with IFN-gamma-inducible protein 10 (CXC chemokine ligand 10) production but not cytokine expression, cytolytic activity, or homing characteristics.
Ejrnaes M; Videbaek N; Christen U; Cooke A; Michelsen BK; von Herrath M
J Immunol; 2005 Mar; 174(5):2746-55. PubMed ID: 15728483
[TBL] [Abstract][Full Text] [Related]
16. Autoreactive CD8 T cells associated with beta cell destruction in type 1 diabetes.
Pinkse GG; Tysma OH; Bergen CA; Kester MG; Ossendorp F; van Veelen PA; Keymeulen B; Pipeleers D; Drijfhout JW; Roep BO
Proc Natl Acad Sci U S A; 2005 Dec; 102(51):18425-30. PubMed ID: 16339897
[TBL] [Abstract][Full Text] [Related]
17. β-cell-specific CD8 T cell phenotype in type 1 diabetes reflects chronic autoantigen exposure.
Skowera A; Ladell K; McLaren JE; Dolton G; Matthews KK; Gostick E; Kronenberg-Versteeg D; Eichmann M; Knight RR; Heck S; Powrie J; Bingley PJ; Dayan CM; Miles JJ; Sewell AK; Price DA; Peakman M
Diabetes; 2015 Mar; 64(3):916-925. PubMed ID: 25249579
[TBL] [Abstract][Full Text] [Related]
18. Transfusion of apoptotic beta-cells induces immune tolerance to beta-cell antigens and prevents type 1 diabetes in NOD mice.
Xia CQ; Peng R; Qiu Y; Annamalai M; Gordon D; Clare-Salzler MJ
Diabetes; 2007 Aug; 56(8):2116-23. PubMed ID: 17496235
[TBL] [Abstract][Full Text] [Related]
19. CD8+ T cell tolerance in nonobese diabetic mice is restored by insulin-dependent diabetes resistance alleles.
Martinez X; Kreuwel HT; Redmond WL; Trenney R; Hunter K; Rosen H; Sarvetnick N; Wicker LS; Sherman LA
J Immunol; 2005 Aug; 175(3):1677-85. PubMed ID: 16034108
[TBL] [Abstract][Full Text] [Related]
20. Towards a curative therapy in type 1 diabetes: remission of autoimmunity, maintenance and augmentation of beta cell mass.
Waldron-Lynch F; von Herrath M; Herold KC
Novartis Found Symp; 2008; 292():146-55; discussion 155-8, 202-3. PubMed ID: 19203097
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
